Biomech Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 5 Year, 15 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 107.61 Cr
as on 16-11-2024
- Revenue -4.83%
(FY 2023)
- Profit -98.88%
(FY 2023)
- Ebitda -35.16%
(FY 2023)
- Net Worth 0.56%
(FY 2023)
- Total Assets 18.71%
(FY 2023)
About Biomech Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹107.61 Cr.
Nagaraj Magadi, Manish Khandelwal, and Sheetal Khandelwal serve as directors at the Company.
- CIN/LLPIN
U24299MP2019PTC050325
- Company No.
050325
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Dec 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Biomech Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nagaraj Magadi  | Director | 11-Dec-2019 | Current |
| Manish Khandelwal | Director | 11-Dec-2019 | Current |
| Sheetal Khandelwal | Director | 28-Sep-2024 | Current |
Financial Performance of Biomech Healthcare.
Biomech Healthcare Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.83% decrease. The company also saw a substantial fall in profitability, with a 98.88% decrease in profit. The company's net worth moved up by a moderate rise of 0.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biomech Healthcare?
In 2023, Biomech Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biobazaar Healthtech Private LimitedActive 3 years 1 monthManish Khandelwal and Sheetal Khandelwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 07 Jan 2021 | ₹1.06 M | Open |
Others Creation Date: 17 Aug 2020 | ₹27.50 Cr | Open |
Hdfc Bank Limited Creation Date: 24 Jun 2020 | ₹80.00 Cr | Open |
How Many Employees Work at Biomech Healthcare?
Unlock and access historical data on people associated with Biomech Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biomech Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biomech Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
